Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Methadone dosing strategies in HIV-infected injection drug uses enrolled in a directly observed therapy program

Article Abstract:

Measured changes in methadone doses and treatment responses after nevirapine (NVP), efavirenz (EFV), ritonavir-boosted lopinavir (LPV/r) or atazanavir (ATV) within a directly observed therapy (DOT) program is evaluated. It is suggested that careful monitoring is needed to ensure methadone withdrawal does not adversely affect the goals of treatment.

Author: Conway, Brian, Fraser, Chris, Tossonian, Harout K., Raffa, Jesse D., Grebely, Jason, Trotter, Brendon, Viljoen, Mark, Mead, Annabel, Khara, Milan, McLean, Mark, Duncan, Fiona, DeVlaming, Stanley
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2007
United States, Science & research, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Methadone (Unit Dose), Care and treatment, Research, Dosage and administration, Methadone hydrochloride, Methadone, Directly observed therapy, Clinical report

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


A prognostic model for HIV seroconversion among injection drug users as a tool for stratification in clinical trials

Article Abstract:

A prognostic model for HIV seroconversion among injection drug users (IDUs) using easy-to measure risk indicators is constructed. Three risk indicators are included in the risk score to predict HIV seroconversion including unstable housing, average cocaine injections per day and having shared a syringe with a known HIV-positive partner.

Author: Vincelette, Jean, Bruneau, Julie, Boileau, Catherine, Al-Nachawati, Hicham, Lamothe, Francois
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2005
Risk factors, Clinical trials, Drug therapy, HIV seropositivity, HIV positive

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Comparison of clinical features of acute HIV-1 infection in patients infected sexually or through injection drug use

Article Abstract:

People who become infected with HIV via drug abuse have the same initial symptoms as those who become infected via sexual intercourse. This was the conclusion of a study of 61 gay men and 26 injection drug users who were infected with HIV.

Author: Cote, Pierre, Conway, Brian, Alary, Michel, Routy, Jean-Pierre, Vanhems, Philippe, Rouleau, Danielle, Tsoukas, Christos, Lefebvre, Eric, LeBlanc, Roger, Bruneau, Julie, Sekaly, Rafick-Pierre
Publisher: Lippincott Williams & Wilkins, WK Health
Publication Name: Journal of Acquired Immune Deficiency Syndromes (1999)
Subject: Health
ISSN: 1525-4135
Year: 2000
Health aspects

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: HIV infection, HIV infections
Similar abstracts:
  • Abstracts: Incidence of immune reconstitution syndrome in HIV/Tuberculosis-Coinfected patients after intiation of generic antiretroviral therapy in India
  • Abstracts: Prevention of HIV/AIDS and other blood-borne diseases among injection drug users: a national survey on the regulation of syringes and needles
  • Abstracts: Prenatal detection of fetal anomalies in pregnancies complicated by insulin-dependent diabetes mellitus. The effects of repeat doses of antenatal corticosteroids on maternal adrenal function
  • Abstracts: A novel viral mechanism for dysregulation of beta-catenin in Kaposi sarcoma-associated herpesvirus latency . Learning old tricks from new viruses
  • Abstracts: Sunlight increases serum 25(OH) vitamin D concentration whereas 1,25(OH)2D3 is unaffected. Results from a general population study in Goteborg, Sweden (the WHO MONICA project)
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.